Begin main content

Ranibizumab (Lucentis) for Myopic Choroidal Neovascularization

Last Updated: February 28, 2014
Result type: Reports
Project Number: SR0373-000
Product Line: Common Drug Review

Generic Name: Ranibizumab

Brand Name: Lucentis

Manufacturer: Novartis Pharmaceuticals Canada Inc.

Indications: Choroidal neovascularisation, myopic

Submission Type: New

Project Status: Complete

Date Recommendation Issued: February 19, 2015

Recommendation Type: List with criteria/condition

Tags

choroidal neovascularization, myopia, diabetes